We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 581

Non-Patent Literature at the PTAB
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • June 12 2018

Typically, the Patent Trial and Appeals Board (PTAB) is thought to disfavor non-patent literaturethat is, “printed publications” under 35 U.S.C


Can Challengers Now Attack Subject Matter Eligibility in Inter Partes Reviews?
  • Banner & Witcoff Ltd
  • USA
  • May 31 2018

The statute authorizing inter partes reviews (IPR) explicitly limits the grounds for cancellation to Sections 102 and 103 of the patent statute:


An overview of patentability in the USA
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA, Global
  • May 10 2018

An overview of patentability in the USA


Upcoming Policy Projects Announced by the Canadian Securities Administrators
  • Bennett Jones LLP
  • Canada
  • April 9 2018

The Canadian Securities Administrators (CSA) announced on March 27, 2018, the initiation of six policy projects aimed at reducing regulatory burdens


Reminder: HR Advice to Management is NOT Privileged
  • Borden Ladner Gervais LLP
  • Canada
  • April 5 2018

In a decision released February 9, 2018, an Ontario Master rejected the claim by an employer that communications between management and its human


Rituxan Patent Spared by Failure to Establish Product Label as “Printed Publication”
  • Marshall Gerstein & Borun LLP
  • USA
  • March 26 2018

A patent relating to a method of treating rheumatoid arthritis using rituximab recently survived its fourth IPR challenge. Celltrion, Inc. v. Biogen


Federal Right To Try Legislation - Is It Any Better? - 2018 Edition
  • Reed Smith LLP
  • USA
  • March 23 2018

A little more than six months ago, we reviewed then-pending federal right-to-try legislation. Since then it’s become a shiny object, capable of


New York Settles EmblemHealth Breach for $575,000
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • March 15 2018

The recent $575,000 settlement with EmblemHealth signals a push from AG Schneiderman “for stronger security laws and holding businesses accountable


Court Determines Debtor's Correct Name on Driver's License for UCC-1 Financing Statement
  • Krieg DeVault
  • USA
  • March 6 2018

On February 1, 2018, the US Bankruptcy Court for the Southern District of Georgia in In re: Kenneth R. Pierce found that the printed name on the


HIPAA Small Breach Notifications Due March 1
  • Davis Wright Tremaine LLP
  • USA
  • February 12 2018

March 1, 2018 is the date by which HIPAA covered entities must notify the U.S. Department of Health and Human Services Office for Civil Rights (OCR